Maria Fortunata Lofiego

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy

Carolina Fazio, Alessia Covre, Ornella Cutaia et al. · Frontiers in Pharmacology · 2018 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy

Andrea Anichini, Alessandra Molla, Gabriella Nicolini et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 34 citations · Full text

Medicine, Immunology, Oncology +17

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial

Teresa Noviello, Anna Maria Di Giacomo, Francesca Pia Caruso et al. · Nature Communications · 2023 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival

Carla Chiarucci, Sara Cannito, Maria Grazia Daffinà et al. · Cancers · 2020 · 26 citations · Full text

Medicine, Immunology, Oncology +17

Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches

Maria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso et al. · Journal of Translational Medicine · 2024 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +17